• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆淀粉样蛋白-β生物标志物与路易体病中的阿尔茨海默病合并症相关。

Plasma amyloid-β biomarkers are associated with Alzheimer's disease comorbidity in Lewy body disease.

作者信息

Noguchi-Shinohara Moeko, Murakami Hidetomo, Sakashita Yasuhiro, Mori Yukiko, Komatsu Junji, Muramatsu Daiki, Hikishima Sadao, Ono Kenjiro

机构信息

Department of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Department of Neurology, School of Medicine, Showa University, Tokyo, Japan.

出版信息

Parkinsonism Relat Disord. 2023 Jun;111:105445. doi: 10.1016/j.parkreldis.2023.105445. Epub 2023 May 13.

DOI:10.1016/j.parkreldis.2023.105445
PMID:37201326
Abstract

No blood biomarkers which can identify Alzheimer's disease pathology in Lewy body disease (LBD) have ever been established. We showed that the plasma amyloid-β (Aβ) /Aβ ratio was significantly decreased in patients with Aβ+ LBD compared with those with Aβ- LBD and it might be a useful biomarker.

摘要

目前尚未建立能够识别路易体病(LBD)中阿尔茨海默病病理特征的血液生物标志物。我们发现,与Aβ阴性的LBD患者相比,Aβ阳性的LBD患者血浆淀粉样蛋白-β(Aβ)/Aβ比值显著降低,它可能是一种有用的生物标志物。

相似文献

1
Plasma amyloid-β biomarkers are associated with Alzheimer's disease comorbidity in Lewy body disease.血浆淀粉样蛋白-β生物标志物与路易体病中的阿尔茨海默病合并症相关。
Parkinsonism Relat Disord. 2023 Jun;111:105445. doi: 10.1016/j.parkreldis.2023.105445. Epub 2023 May 13.
2
Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.路易体疾病谱系中脑和小脑中的路易体和阿尔茨海默病样病理特征
Neuropathol Appl Neurobiol. 2016 Aug;42(5):451-62. doi: 10.1111/nan.12308. Epub 2016 Apr 1.
3
Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.路易体病与阿尔茨海默病的海马亚区病理负担。
Neuropathol Appl Neurobiol. 2020 Dec;46(7):707-721. doi: 10.1111/nan.12659. Epub 2020 Sep 24.
4
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.阿尔茨海默病和路易体痴呆患者红细胞中的α-突触核蛋白异源二聚体。
J Alzheimers Dis. 2021;80(2):885-893. doi: 10.3233/JAD-201038.
5
The molecular spectrum of amyloid-beta (Aβ) in neurodegenerative diseases beyond Alzheimer's disease.神经退行性疾病中除阿尔茨海默病以外的淀粉样-β(Aβ)的分子谱。
Brain Pathol. 2024 Jan;34(1):e13210. doi: 10.1111/bpa.13210. Epub 2023 Aug 31.
6
Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.神经病理学混合性阿尔茨海默病和路易体病:临床表型之间病理蛋白聚集物的负担不同。
Acta Neuropathol. 2015 May;129(5):729-48. doi: 10.1007/s00401-015-1406-3. Epub 2015 Mar 11.
7
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.阿尔茨海默病脑脊液生物标志物可预测路易体痴呆的认知衰退。
Mov Disord. 2016 Aug;31(8):1203-8. doi: 10.1002/mds.26668. Epub 2016 Jun 14.
8
Multimodal in vivo and postmortem assessments of tau in Lewy body disorders.路易体疾病中 tau 的多模态体内和死后评估。
Neurobiol Aging. 2020 Dec;96:137-147. doi: 10.1016/j.neurobiolaging.2020.08.003. Epub 2020 Aug 21.
9
Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load.阿尔茨海默病和路易体痴呆患者新皮质中转化生长因子β2升高与疾病严重程度及可溶性Aβ42负荷相关。
J Alzheimers Dis. 2017;56(1):157-166. doi: 10.3233/JAD-160781.
10
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia.阿尔茨海默病、路易体痴呆和帕金森病痴呆中的脑脊液淀粉样β肽。
Brain. 2006 May;129(Pt 5):1177-87. doi: 10.1093/brain/awl063. Epub 2006 Apr 6.

引用本文的文献

1
Plasma amyloid-β precursor protein /amyloid-β ratio is associated with cognition in Alzheimer's disease.血浆淀粉样前体蛋白/淀粉样β蛋白比值与阿尔茨海默病的认知功能相关。
J Prev Alzheimers Dis. 2025 Jan;12(1):100003. doi: 10.1016/j.tjpad.2024.100003. Epub 2025 Jan 1.
2
The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics.α-突触核蛋白、淀粉样β和tau 蛋白在路易体疾病中的作用机制:发病机制、早期检测和治疗。
Int J Mol Sci. 2023 Jun 17;24(12):10215. doi: 10.3390/ijms241210215.